When subsidiaries of Mylan NV cried foul over alleged conflicts of interest and sued to block Kirkland & Ellis from representing Teva Pharmaceutical Industries Ltd. in a heated takeover battle, Kirkland derided the lawsuit as a tactical ploy to delay Teva’s hostile bid.
Ploy or not, the lawsuit, led by Wilson Sonsini Goodrich & Rosati partner Michael Sommer, gave Mylan an advantage that its opponents never managed to overcome.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
